A committee at the Centers for Disease Control voted this week to increase the recommended age for males to become vaccinated for the human papillomavirus to age 26, an increase from age 21.
The committee also suggested men as old as 45 could benefit from the vaccine.
Dr. Bill Schaffner, MD, a professor of preventive medicine in the Department of Health Policy, explains in Contagion why that's an important — and good — decision for men to make.
“There are many people over the age of 27 who are not in monogamous relationships and some of those individuals, particularly those previously in a monogamous relationship, [are] back on the social scene and they may want to get protected,” Schaffner said “Obviously the older we are, the more likely it is statistically that we have had contact with the human papillomavirus…On the basis of shared clinical decision making, it’s a generous and appropriate decision.”
Read the full report in ContagionLive here: https://www.contagionlive.com/news/cdc-committee-votes-to-expand-hpv-vaccine-recommendations-for-men-up-to-age-26